Lipum has completed its Phase I clinical trial for SOL-116, demonstrating a favorable safety profile and predictable pharmacokinetics in both healthy volunteers and rheumatoid arthritis patients.
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.